Authors:
HAYS SJ
CAPRATHE BW
GILMORE JL
AMIN N
EMMERLING MR
MICHAEL W
NADIMPALLI R
NATH R
RASER KJ
STAFFORD D
WATSON D
WANG K
JAEN JC
Citation: Sj. Hays et al., 2-AMINO-4H-3,1-BENZOXAZIN-4-ONES AS INHIBITORS OF C1R SERINE-PROTEASE, Journal of medicinal chemistry, 41(7), 1998, pp. 1060-1067
Authors:
TECLE H
BARRETT SD
LAUFFER DJ
AUGELLISZAFRAN C
BRANN MR
CALLAHAN MJ
CAPRATHE BW
DAVIS RE
DOYLE PD
EUBANKS D
LIPINISKI W
MIRZADEGAN T
MOOS WH
MORELAND DW
NELSON CB
PAVIA MR
RABY C
SCHWARZ RD
SPENCER CJ
THOMAS AJ
JAEN JC
Citation: H. Tecle et al., DESIGN AND SYNTHESIS OF M1-SELECTIVE MUSCARINIC AGONISTS - (R)-(-)-(Z)-1-AZABICYCLO[2.2.1]HEPTAN-3-ONE, O-(3-(3'-METHOXYPHENYL)-2-PROPYNYL)OXIME MALEATE (CI-1017), A FUNCTIONALLY M1-SELECTIVE MUSCARINIC AGONIST, Journal of medicinal chemistry, 41(14), 1998, pp. 2524-2536
Authors:
SCHWARZ RD
CALLAHAN MJ
DAVIS RE
JAEN JC
TECLE H
Citation: Rd. Schwarz et al., DEVELOPMENT OF M-1 SUBTYPE-SELECTIVE MUSCARINIC AGONISTS FOR ALZHEIMERS-DISEASE - TRANSLATION OF IN-VITRO SELECTIVITY INTO IN-VIVO EFFICACY, Drug development research, 40(2), 1997, pp. 133-143
Authors:
BARRETT SD
JAEN JC
CAPRATHE BW
THOMAS AJ
TECLE H
Citation: Sd. Barrett et al., EFFICIENT SYNTHESIS OF EXO-1-AZABICYCLO[2.2.1]HEPTAN-3-OL, Organic preparations and procedures international, 29(3), 1997, pp. 330-335
Authors:
GROSS J
AUGELLISZAFRAN CE
CZECHE S
FRIEBE T
JAEN JC
PENVOSEYI JR
SCHWARZ RD
MUTSCHLER E
LAMBRECHT G
Citation: J. Gross et al., PD102807 - A NOVEL M-4-SELECTIVE MUSCARINIC ANTAGONIST, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 62-62
Authors:
SCHWARZ RD
NELSON CB
AUGELLISZAFRAN CE
PENVOSE JR
JAEN JC
WILEY J
FREY KA
Citation: Rd. Schwarz et al., PHARMACOLOGICAL CHARACTERIZATION OF PD182807 - AN M4 SUBTYPE-SELECTIVE MUSCARINIC ANTAGONIST, Life sciences, 60(13-14), 1997, pp. 10-10
Authors:
GROSS J
AUGELLISZAFRAN CE
CZECHE S
FRIEBE T
JAEN JC
PENVOSEYI JR
SCHWARZ RD
MUTSCHLER E
LAMBRECHT G
Citation: J. Gross et al., FUNCTIONAL-CHARACTERIZATION OF PD102807 - A NOVEL M(4)-SELECTIVE MUSCARINIC ANTAGONIST, Life sciences, 60(13-14), 1997, pp. 12-12
Authors:
GILMORE JL
HAYS SJ
CAPRATHE BW
LEE C
EMMERLING MR
MICHAEL W
JAEN JC
Citation: Jl. Gilmore et al., SYNTHESIS AND EVALUATION OF 2-ARYL-4H-3,1-BENZOXAZIN-4-ONES AS C1R SERINE-PROTEASE INHIBITORS, Bioorganic & medicinal chemistry letters, 6(6), 1996, pp. 679-682
Authors:
GLASE SA
AKUNNE HC
HEFFNER TG
JAEN JC
MACKENZIE RG
MELTZER LT
PUGSLEY TA
SMITH SJ
WISE LD
Citation: Sa. Glase et al., ARYL 1-BUT-3-YNYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINES AS POTENTIAL ANTIPSYCHOTIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS, Journal of medicinal chemistry, 39(16), 1996, pp. 3179-3187
Citation: Wf. Pool et al., IDENTIFICATION OF A 3-HYDROXYLATED TACRINE METABOLITE IN RAT AND MAN - METABOLIC PROFILING IMPLICATIONS AND PHARMACOLOGY, Journal of medicinal chemistry, 39(15), 1996, pp. 3014-3018
Authors:
SCHWARZ RD
SPENCER CJ
JAEN JC
MIRZADEGAN T
MORELAND D
TECLE H
THOMAS AJ
Citation: Rd. Schwarz et al., MUTATIONS OF ASPARTATE-103 IN THE HM2 RECEPTOR AND ALTERATIONS IN RECEPTOR-BINDING PROPERTIES OF MUSCARINIC AGONISTS, Life sciences, 56(11-12), 1995, pp. 923-929
Authors:
TECLE H
LAUFFER DJ
DAVIS RE
MIRZADEGAN T
MORELAND DW
SCHWARZ RD
THOMAS AJ
RABY C
JAEN JC
Citation: H. Tecle et al., ARYLENEYNE 1-AZABICYCLO[2.2.1]HEPTAN-3-ONE OXIMES - POTENT MUSCARINICAGONISTS, Life sciences, 56(11-12), 1995, pp. 1003-1003
Authors:
AUGELLISZAFRAN CE
BLANKLEY CJ
JAEN JC
MORELAND DW
NELSON CB
PENVOSE JR
SCHWARZ RD
THOMAS AJ
Citation: Ce. Augelliszafran et al., IDENTIFICATION AND CHARACTERIZATION OF M1 SELECTIVE MUSCARINIC ANTAGONISTS, Life sciences, 56(11-12), 1995, pp. 1017-1017
Authors:
NELSON CB
AUGELLISZAFRAN CE
CALLAHAN MJ
CHRISTOFFERSEN C
JAEN JC
MELTZER LT
PENVOSE JR
SCHWARZ RD
THOMAS AJ
WILEY J
Citation: Cb. Nelson et al., PHARMACOLOGICAL CHARACTERIZATION OF PD150714 - AN M1 SELECTIVE MUSCARINIC ANTAGONIST, Life sciences, 56(11-12), 1995, pp. 1017-1017
Citation: Ta. Pugsley et al., CI-1007, A DOPAMINE PARTIAL AGONIST AND POTENTIAL ANTIPSYCHOTIC AGENT.1. NEUROCHEMICAL EFFECTS, The Journal of pharmacology and experimental therapeutics, 274(2), 1995, pp. 898-911
Authors:
JAEN JC
LABORDE E
BUCSH RA
CAPRATHE BW
SORENSON RJ
FERGUS J
SPIEGEL K
MARKS J
DICKERSON MR
DAVIS RE
Citation: Jc. Jaen et al., KYNURENIC ACID-DERIVATIVES INHIBIT THE BINDING OF NERVE GROWTH-FACTOR(NGF) TO THE LOW-AFFINITY P75 NGF RECEPTOR, Journal of medicinal chemistry, 38(22), 1995, pp. 4439-4445
Authors:
SPIEGEL K
AGRAFIOTIS D
CAPRATHE B
DAVIS RE
DICKERSON MR
FERGUS JH
HEPBURN TW
MARKS JS
VANDORF M
WIELAND DM
JAEN JC
Citation: K. Spiegel et al., PD-90780, A NONPEPTIDE INHIBITOR OF NERVE GROWTH-FACTORS BINDING TO THE P75 NGF RECEPTOR, Biochemical and biophysical research communications, 217(2), 1995, pp. 488-494
Authors:
WRIGHT JL
CAPRATHE BW
DOWNING DM
GLASE SA
HEFFNER TG
JAEN JC
JOHNSON SJ
KESTEN SR
MACKENZIE RG
MELTZER LT
PUGSLEY TA
SMITH SJ
WISE LD
WUSTROW DJ
Citation: Jl. Wright et al., THE DISCOVERY AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF YDRO-4-PHENYL-1-[(ARYLCYCLOHEXENYL)ALKYL]PYRIDINES - DOPAMINE AUTORECEPTOR AGONISTS AND POTENTIAL ANTIPSYCHOTIC AGENTS, Journal of medicinal chemistry, 37(21), 1994, pp. 3523-3533
Authors:
JAEN JC
KROPKO ML
THEISS JC
WOLD S
CAPRATHE BW
WISE LD
Citation: Jc. Jaen et al., ASSESSMENT OF MUTAGENIC POTENTIAL IN A SERIES OF COMPOUNDS STRUCTURALLY RELATED TO 2-AMINO-3-METHYLIMIDAZO [4,5-F]QUINOLINE (IQ), European journal of medicinal chemistry, 28(7-8), 1993, pp. 547-553
Citation: Lt. Meltzer et al., PHARMACOLOGICAL PROFILE OF THE DOPAMINE PARTIAL AGONIST, (+ --PD-128483 AND ITS ENANTIOMERS/, The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1177-1189